Ken Griffin Bruker Corp Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bruker Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 2,712,456 shares of BRKR stock, worth $87.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,712,456
Previous 27,600
9727.74%
Holding current value
$87.8 Million
Previous $1.15 Million
9600.78%
% of portfolio
0.02%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding BRKR
# of Institutions
405Shares Held
117MCall Options Held
225KPut Options Held
743K-
T. Rowe Price Investment Management, Inc. Baltimore, MD11.4MShares$370 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$338 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.83MShares$318 Million0.01% of portfolio
-
Pallas Capital Advisors LLC Braintree, MA9.5MShares$307 Million16.14% of portfolio
-
Orbis Allan Gray LTD Hamilton, D04.68MShares$151 Million1.26% of portfolio
About BRUKER CORP
- Ticker BRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 148,138,000
- Market Cap $4.79B
- Description
- Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...